跳至主要内容
临床试验/IRCT2013102115105N1
IRCT2013102115105N1已完成3 期

Effect of Pioglitazone on proteinuria, inflammatory and oxidative markers in patient with diabetic nephropathy

Vice chancellor for research, Tabriz University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • (The patient with Diabetic nephropathy with Diabet type2; Glomerular filtration rate equal or greater than 30; Age graeter 18 & smaller 65 years old; Agreement to participate in the study) Exclusion criteria: (Glomerular Filtration Rate smaller than 30; Dyspnea; CHF; Liver failure; General edema; Age smaller than 18 & greater than 65 years old; Body Mass Index equal or greater than 40

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Tabriz University of Medical Sciences

相似试验

Effect of a lowering blood glucose drug on protein... | 临床试验